Bharat Biotech's Covaxin Shows Promising Results | Coronavirus Vaccine Update

Bharat Biotech's Covaxin Shows Promising Results | Coronavirus Vaccine Update

Bharat Biotech's Covaxin Show Promising Results; Well Tolerated In All Groups In Phase 1 & 2 Trials

Coronavirus Update: Animal Trials Of Bharat Biotech COVID-19 vaccine Covaxin Successful

Bharat Biotech's Covaxin: All You Need To Know About Covid Vaccine | India Today

Coronavirus Vaccine| Bharat Biotech's Top Brass Slams Covaxin Critics| Covid-19 News | Covid Vaccine

COVID vaccine updates: Bharat Biotech's Covaxin displayed long-term antibody response

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| Breaking

Coronavirus India Vaccine: India Approves Vaccines From Bharat Biotech And Oxford-Astrazeneca

Bharat Biotech's Covaxin 60% Effective, How Soon Covid Vaccine Be Available In Markets?

Coronavirus Vaccine Update: Bharat Biotech Plans Likely To Launch Covaxin Post March 2021

Covid Vaccine Update| First Batch Of Bharat Biotech's Covaxin To Arrive In Delhi Shortly| Breaking

Coronavirus Vaccine Update| Review Of Covid Vaccine Applications of Pfizer, SII, Bharat Biotech

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trials

Bharat Biotech's Vaccine Cleared By Panel, Regulator's Approval Awaited

NDTV

Bharat Biotech Promises Medical Care, Compensation In Case Of Adverse Affects From Covaxin

Coronavirus vaccine Update | Covaxin Production To Be Doubled By May-June 2021 | Breaking News

Coronavirus Vaccine | Covaxin Works Against UK Strain, Variant Found in India: Bharat Biotech

NDTV

Bharat Biotech Issues Clarification On Anil Vij Being Covid Positive After Vaccine Trials

Speed News|Bharat Biotech's Nasal Vaccine Deal; Dr Reddy's-Russia Vaccine Trials; J&J Vaccine Trials

Bharat Biotech says COVID-19 vaccine shows 81% interim efficacy

The Economic Times